Form 4 for TSHA Taysha Gene Therapies, Inc.
Accepted 2022-02-03 00:00:00 ET · period of report 2022-02-02 · accession 0001209191-22-006652 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-03 | 2022-02-02 | TSHA | Nagendran Sukumar | Dir | P - Purchase | $8.01 | +10.0K | 29.2K | +52% | +$80.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-02 | P | A | 10,000 | $8.01 | 29,226 | D | — | — |